In response to significant interest from people and medical professionals in Canada
, Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF, Forum) announced on Thursday that it is expanding the hours of operation at its Toronto location to provide its ketamine-assisted psychedelic therapies on evenings and Saturdays. The Company also pointed out that this is its busiest week to date at the centre.
The Company added that its proprietary digital mental health platform, Portal, began rolling out across North America to people currently participating in Field Trip’s psychedelic-enhanced therapy programs. Field Trip is also actively exploring options to enhance access globally to those who are interested in investing in Field Trip through recognized exchanges.
For more on these stories, click
here.
FTRP, a leader in the development and delivery of psychedelic therapies – reported its
Q2 2021 fiscal quarter results for the three and six months ended September 30th, 2020.
FULL DISCLOSURE: Field Trip Health Ltd. is a client of Stockhouse Publishing.